TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial
Brief Summary: The investigators investigate if combined progressive aerobic training and resistance training improve metabolic control and fat mass in patients with type 2 diabetes who are eating a modified paleolithic diet. The investigators randomize 40 participants to two groups: 1) Modified paleolithic diet and exercise under observation 3 sessions/week, 2) Modified paleolithic diet and general advice about exercise.

The investigators primary hypothesis is that in patients with type 2 diabetes decreases fat mass more with progressive exercise under observation and a modified paleolithic diet than with general advice about exercise and a modified paleolithic diet.


Options:
A: Arm Label: Exercise under observation; Type: EXPERIMENTAL; Interventions: Behavioral: Modified paleolithic diet and exercise under observation | Arm Label: General advice on exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Modified paleolithic diet and general advice on exercise | Intervention Type: BEHAVIORAL; Name: Modified paleolithic diet and exercise under observation; Assigned to Arm(s): Exercise under observation | Intervention Type: BEHAVIORAL; Name: Modified paleolithic diet and general advice on exercise; Assigned to Arm(s): General advice on exercise
B: Arm Label: DIPI: Danish national dietary guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: DIPI: Specific IHD dietary guideline; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: Normal dietary habits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: DIPI; Assigned to Arm(s): DIPI: Danish national dietary guidelines, DIPI: Specific IHD dietary guideline
C: Arm Label: Full fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Full fat dairy | Arm Label: Low fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Low fat dairy | Arm Label: Control group; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Full fat dairy; Assigned to Arm(s): Full fat dairy group | Intervention Type: OTHER; Name: Low fat dairy; Assigned to Arm(s): Low fat dairy group | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control group
D: Intervention Type: BEHAVIORAL; Name: Mono Unsaturated Fatty Acids in Obesity; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial
Brief Summary: The investigators investigate if combined progressive aerobic training and resistance training improve metabolic control and fat mass in patients with type 2 diabetes who are eating a modified paleolithic diet. The investigators randomize 40 participants to two groups: 1) Modified paleolithic diet and exercise under observation 3 sessions/week, 2) Modified paleolithic diet and general advice about exercise.

The investigators primary hypothesis is that in patients with type 2 diabetes decreases fat mass more with progressive exercise under observation and a modified paleolithic diet than with general advice about exercise and a modified paleolithic diet.


Options:
A: Arm Label: low fat hypocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dietary intervention | Arm Label: Low carbohydrate hypocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dietary intervention | Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): Low carbohydrate hypocaloric diet, low fat hypocaloric diet
B: Arm Label: Intervention; Type: N/A; Interventions: Behavioral: educational/counseling intervention, Behavioral: therapeutic dietary intervention | Arm Label: Control; Type: N/A; Interventions: Behavioral: therapeutic dietary intervention | Intervention Type: BEHAVIORAL; Name: educational/counseling intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: therapeutic dietary intervention; Assigned to Arm(s): Control, Intervention
C: Arm Label: Full fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Full fat dairy | Arm Label: Low fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Low fat dairy | Arm Label: Control group; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Full fat dairy; Assigned to Arm(s): Full fat dairy group | Intervention Type: OTHER; Name: Low fat dairy; Assigned to Arm(s): Low fat dairy group | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control group
D: Arm Label: Exercise under observation; Type: EXPERIMENTAL; Interventions: Behavioral: Modified paleolithic diet and exercise under observation | Arm Label: General advice on exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Modified paleolithic diet and general advice on exercise | Intervention Type: BEHAVIORAL; Name: Modified paleolithic diet and exercise under observation; Assigned to Arm(s): Exercise under observation | Intervention Type: BEHAVIORAL; Name: Modified paleolithic diet and general advice on exercise; Assigned to Arm(s): General advice on exercise

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress, Ongoing Self Monitoring and Ischemic Heart Disease Rehabilitation, a Randomized Controlled Trial (SongHeart)
Brief Summary: The purpose of the study is to examine if bio feedback guided stress management by daily measurement of pressure pain sensitivity followed by acupressure reduces signs of depression and number clinical stress signs and increases quality of life in patients with stable, ischemic heart disease


Options:
A: Arm Label: Traditional Acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Minimal Acupuncture; Type: ACTIVE_COMPARATOR; Interventions: Other: Acupuncture | Arm Label: Placebo Acupuncture; Type: PLACEBO_COMPARATOR; Interventions: Other: Acupuncture | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Minimal Acupuncture, Placebo Acupuncture, Traditional Acupuncture
B: Arm Label: Traditional Acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Minimal Acupuncture; Type: ACTIVE_COMPARATOR; Interventions: Other: Acupuncture | Arm Label: Placebo Acupuncture; Type: PLACEBO_COMPARATOR; Interventions: Other: Acupuncture | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Minimal Acupuncture, Placebo Acupuncture, Traditional Acupuncture
C: Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): N/A
D: Arm Label: stress management, acupressure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: pressure pain sensitivity measure followed bu acupressure | Arm Label: bio feedback guided, stress management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: pressure pain sensitivity measure followed bu acupressure; Assigned to Arm(s): stress management, acupressure

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD
Brief Summary: The purpose of this study is to evaluate whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of improved health-related quality of life and reduced access to hospital facilities. In addition, the trial evaluates the economic and organisational impact of the new services, and examine their acceptability by patients and health professionals.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Bundle; Type: EXPERIMENTAL; Interventions: Behavioral: Bundle tool | Intervention Type: BEHAVIORAL; Name: Bundle tool; Assigned to Arm(s): Bundle
B: Arm Label: CHF patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: COPD patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: CHF patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: COPD patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IVR-Enhanced Care; Assigned to Arm(s): CHF patients, IVR-Enhanced Care, COPD patients, IVR-Enhanced Care
C: Arm Label: usual care; Type: OTHER; Interventions: Behavioral: usual care | Arm Label: cooperation; Type: EXPERIMENTAL; Interventions: Behavioral: closer collaboration between hospital and primary healthcare system | Intervention Type: BEHAVIORAL; Name: closer collaboration between hospital and primary healthcare system; Assigned to Arm(s): cooperation | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): usual care
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: self-monitoring for patients with severe COPD | Arm Label: Nurse monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: nurse-monitoring for patients with severe COPD | Intervention Type: PROCEDURE; Name: self-monitoring for patients with severe COPD; Assigned to Arm(s): Self monitoring for patients with COPD | Intervention Type: PROCEDURE; Name: nurse-monitoring for patients with severe COPD; Assigned to Arm(s): Nurse monitoring for patients with COPD

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD
Brief Summary: The purpose of this study is to evaluate whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of improved health-related quality of life and reduced access to hospital facilities. In addition, the trial evaluates the economic and organisational impact of the new services, and examine their acceptability by patients and health professionals.


Options:
A: Arm Label: comprehensive care programme; Type: ACTIVE_COMPARATOR; Interventions: Other: Comprehensive care programme | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Comprehensive care programme; Assigned to Arm(s): comprehensive care programme
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: self-monitoring for patients with severe COPD | Arm Label: Nurse monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: nurse-monitoring for patients with severe COPD | Intervention Type: PROCEDURE; Name: self-monitoring for patients with severe COPD; Assigned to Arm(s): Self monitoring for patients with COPD | Intervention Type: PROCEDURE; Name: nurse-monitoring for patients with severe COPD; Assigned to Arm(s): Nurse monitoring for patients with COPD
C: Intervention Type: BEHAVIORAL; Name: Intermediate care package; Assigned to Arm(s): N/A
D: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD
Brief Summary: The purpose of this study is to evaluate whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of improved health-related quality of life and reduced access to hospital facilities. In addition, the trial evaluates the economic and organisational impact of the new services, and examine their acceptability by patients and health professionals.


Options:
A: Intervention Type: BEHAVIORAL; Name: Intermediate care package; Assigned to Arm(s): N/A
B: Arm Label: Tool + Self-management Support Program; Type: EXPERIMENTAL; Interventions: Device: Tool, Behavioral: Self-management Support Program | Arm Label: Self- management Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management Support Program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tool; Assigned to Arm(s): Tool + Self-management Support Program | Intervention Type: BEHAVIORAL; Name: Self-management Support Program; Assigned to Arm(s): Self- management Support Program, Tool + Self-management Support Program
C: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: self-monitoring for patients with severe COPD | Arm Label: Nurse monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: nurse-monitoring for patients with severe COPD | Intervention Type: PROCEDURE; Name: self-monitoring for patients with severe COPD; Assigned to Arm(s): Self monitoring for patients with COPD | Intervention Type: PROCEDURE; Name: nurse-monitoring for patients with severe COPD; Assigned to Arm(s): Nurse monitoring for patients with COPD
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Ususal care | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: RT management | Intervention Type: OTHER; Name: RT management; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Ususal care; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD
Brief Summary: The purpose of this study is to evaluate whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of improved health-related quality of life and reduced access to hospital facilities. In addition, the trial evaluates the economic and organisational impact of the new services, and examine their acceptability by patients and health professionals.


Options:
A: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls
B: Arm Label: Intervention- Home Pulmonary Rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention- Home-based Pulmonary Rehabilitation | Arm Label: Control- Choice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention- Home-based Pulmonary Rehabilitation; Assigned to Arm(s): Intervention- Home Pulmonary Rehabilitation
C: Arm Label: Case Management and Self-Management Education; Type: EXPERIMENTAL; Interventions: Other: Case Management and Self-Management Education | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Case Management and Self-Management Education | Intervention Type: OTHER; Name: Case Management and Self-Management Education; Assigned to Arm(s): Case Management and Self-Management Education, Usual Care
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: self-monitoring for patients with severe COPD | Arm Label: Nurse monitoring for patients with COPD; Type: EXPERIMENTAL; Interventions: Procedure: nurse-monitoring for patients with severe COPD | Intervention Type: PROCEDURE; Name: self-monitoring for patients with severe COPD; Assigned to Arm(s): Self monitoring for patients with COPD | Intervention Type: PROCEDURE; Name: nurse-monitoring for patients with severe COPD; Assigned to Arm(s): Nurse monitoring for patients with COPD

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decision Aid to Technologically Enhance Shared Decision Making
Brief Summary: Physicians face a challenge in promoting colorectal cancer screening (CRCS) in the face of multiple competing demands. A decision aid (DA) that clarifies patient preferences and improves decision quality could aid shared decision making (SDM) and be effective at increasing CRCS rates. However, exactly how such DA improves SDM is not clear. This 4-year R01 study funded by the National Cancer Institute seeks to provide detailed understanding of how an interactive DA affects patient-physician communication and SDM, and ultimately CRCS adherence.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention with Colorectal Website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Colorectal Web | Intervention Type: BEHAVIORAL; Name: Colorectal Web; Assigned to Arm(s): Intervention with Colorectal Website
B: Arm Label: Usual Support Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual-Support | Arm Label: Enhanced Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Support | Intervention Type: BEHAVIORAL; Name: Enhanced Support; Assigned to Arm(s): Enhanced Support Group | Intervention Type: BEHAVIORAL; Name: Usual-Support; Assigned to Arm(s): Usual Support Group
C: Arm Label: FRAX + Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: FRAX + Decision Aid | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: FRAX estimated fracture risk; Type: EXPERIMENTAL; Interventions: Behavioral: FRAX estimated fracture risk | Intervention Type: BEHAVIORAL; Name: FRAX + Decision Aid; Assigned to Arm(s): FRAX + Decision Aid | Intervention Type: BEHAVIORAL; Name: FRAX estimated fracture risk; Assigned to Arm(s): FRAX estimated fracture risk
D: Arm Label: Rating and Ranking Group; Type: OTHER; Interventions: Other: Rating and Ranking Task | Arm Label: Discrete Choice Group; Type: OTHER; Interventions: Other: Discrete Choice Task | Arm Label: Balance Sheet Group; Type: OTHER; Interventions: Other: Balance Sheet Task | Intervention Type: OTHER; Name: Rating and Ranking Task; Assigned to Arm(s): Rating and Ranking Group | Intervention Type: OTHER; Name: Discrete Choice Task; Assigned to Arm(s): Discrete Choice Group | Intervention Type: OTHER; Name: Balance Sheet Task; Assigned to Arm(s): Balance Sheet Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pulmaquin® in the Management of Chronic Lung Infections With Pseudomonas Aeruginosa in Subjects With Non-Cystic Fibrosis Bronchiectasis, Including 28 Day Open-Label Extension and Pharmacokinetic Substudy (ORBIT-3)
Brief Summary: This study (ARD-3150-1201, ORBIT-3) will evaluate the safety and efficacy of inhaled Pulmaquin (ciprofloxacin dispersion for inhalation) compared to inhaled placebo in subjects who have a confirmed diagnosis of non-cystic fibrosis (non-CF) bronchiectasis with a history of pulmonary exacerbations and chronic P. aeruginosa infections.


Options:
A: Arm Label: Ciprofloxacin dispersion for inhalation; Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin dispersion for inhalation | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ciprofloxacin dispersion for inhalation; Assigned to Arm(s): Ciprofloxacin dispersion for inhalation | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: AZLI-AZLI; Type: EXPERIMENTAL; Interventions: Drug: AZLI | Arm Label: Placebo-AZLI; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZLI, Drug: Placebo | Intervention Type: DRUG; Name: AZLI; Assigned to Arm(s): AZLI-AZLI, Placebo-AZLI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo-AZLI
C: Arm Label: Ciprofloxacin dispersion for inhalation; Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin dispersion for inhalation | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ciprofloxacin dispersion for inhalation; Assigned to Arm(s): Ciprofloxacin dispersion for inhalation | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: AZLI-AZLI; Type: EXPERIMENTAL; Interventions: Drug: AZLI | Arm Label: Placebo-AZLI; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZLI, Drug: Placebo | Intervention Type: DRUG; Name: AZLI; Assigned to Arm(s): AZLI-AZLI, Placebo-AZLI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo-AZLI

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies
Brief Summary: WISER Survivor is a one year weight loss and exercise study for sedentary breast cancer survivors who are overweight or obese with breast cancer related lymphedema. There will be four groups in this trial: exercise only, weight loss only, exercise and weight-loss combined, and a control group. The primary purpose of this study is to test the effects of these interventions on clinical lymphedema outcomes. Secondary outcomes include weight loss, breast cancer related biomarkers, and quality of life. To the extent that funding will be available, participants will be followed long term to examine effects on recurrence and mortality.


Options:
A: Arm Label: Lymphedema Care Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise only; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Weight loss only; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Loss Intervention | Arm Label: Exercise and Weight loss combined; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention, Behavioral: Weight Loss Intervention | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Exercise only | Intervention Type: BEHAVIORAL; Name: Weight Loss Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Weight loss only
B: Arm Label: Arm I: Yoga Therapy; Type: EXPERIMENTAL; Interventions: Procedure: Yoga Therapy | Arm Label: Arm II: Wait-List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Yoga Therapy; Assigned to Arm(s): Arm I: Yoga Therapy
C: Arm Label: All patients; Type: N/A; Interventions: N/A
D: Arm Label: aerobic resistance; Type: EXPERIMENTAL; Interventions: Behavioral: aerobic resistance exercise | Arm Label: home based physical activity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: home based health promotion | Intervention Type: BEHAVIORAL; Name: aerobic resistance exercise; Assigned to Arm(s): aerobic resistance | Intervention Type: BEHAVIORAL; Name: home based health promotion; Assigned to Arm(s): home based physical activity

Answer: A